Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polomar Health ServicesPMHS EV-to-FCF is -9.40 as of Jul. 24, 2026. The stock has 4 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 246913.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Polomar Health Services's Enterprise Value is $2.98 Mil.
Polomar Health Services's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.32 Mil. Therefore, Polomar Health Services's EV-to-FCF for today is -9.40.
The historical rank and industry rank for Polomar Health Services's EV-to-FCF or its related term are showing as below:
PMHS'
s EV-to-FCF Range Over the Past 10 Years
Min: -1763 Med: -30.79 Max: -0.29
Current: -9.4
During the past 7 years, the highest EV-to-FCF of Polomar Health Services was -0.29. The lowest was -1763.00. And the median was -30.79.
PMHS's EV-to-FCF is ranked worse than 100% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.87
vs PMHS: -9.40
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Polomar Health Services (OTCPK:PMHS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Polomar Health Services's PE Ratio (TTM) for today is calculated as:
Polomar Health Services's share price for today is $0.08.
Polomar Health Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.370.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Polomar Health Services's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's EV-to-FCF falls into.
Polomar Health Services's current Enterprise Value is $2.98 Mil.
Polomar Health Services's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services (PMHS) has a EV-to-FCF of -9.40 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #999999 out of 405 companies in the Healthcare Providers & Services industry.
Is Polomar Health Services' EV-to-FCF too high?
Polomar Health Services' current EV-to-FCF is -9.40. Based on the distribution chart, Polomar Health Services ranks #999999 out of 405 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Polomar Health Services' EV-to-FCF compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #999999 out of 405 companies for EV-to-FCF. This places Polomar Health Services in the lower half of its industry. The industry median EV-to-FCF is 17.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.87, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current EV-to-FCF is -9.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.52, compared to a current price of $0.08 — trading 99.4% below its estimated fair value. The current EV-to-FCF is -9.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current EV-to-FCF is -9.40 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
